CLINICAL_TRIALS
trial_result
· 2016-05-09
Clinical Trial Update: Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism) [Phase 2]
Summary
A Phase 2 study evaluating prednisone for severe systemic cholesterol embolism (cholesterol crystal embolism) was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Toulouse | Conditions: Cholesterol Embolism Systemic | Phase 2 | Status: TERMINATED